Related Experiment Video
Updated: Jan 7, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Cost-effectiveness analysis of commercial Chinese polyherbal preparations for primary insomnia: based on network
Sihong Yang1,2, Fanya Yu3, Xinghua Xiang1,2
1Institute of Basic Research In Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
Objectives:
Building upon prior systematic reviews and network meta-analyses, this study evaluated the cost-effectiveness of four commercial Chinese polyherbal preparations (CCPPs)-Tian Meng Oral Liquid/Capsules (TM), Shen-Qi-Wu-Wei-Zi Tablets (SQWWZ), Wu Ling Capsules (WL), and Bai-Le-Mian Capsules (BLM)-for treating primary insomnia. Comparative findings informed clinical decision-making and health policy formulation.
Methods:
A cost-effectiveness analysis was conducted from a healthcare system perspective. A patient disease course model was developed using systematic literature search and network meta-analysis combined with drug pricing data. Intervention strategies (monotherapy or combination therapy) were simulated to assess per-capita costs and health outcomes. Incremental cost-effectiveness ratios were calculated and compared against the willingness-to-pay threshold. Deterministic sensitivity analysis (DSA), Monte Carlo simulations for probabilistic sensitivity analysis and cost-effectiveness acceptability curves were used to test the overall stability and acceptable probability of the evaluation results.
Results:
At a WTP threshold of ¥89,358.00 per quality-adjusted life year (QALY), the combination of TM and benzodiazepines (BZDs) ranked highest in terms of cost-effectiveness, followed by WL, BLM, and SQWWZ. When the WTP threshold exceeded ¥5,897.63 per QALY, the probability that TM + BZDs was more cost-effective than WL increased. Likewise, when the WTP threshold was above ¥19,658.76 per QALY, the probability that BLM was more cost-effective than SQWWZ became greater.
Conclusion:
Within the 60-day time horizon of this analysis, TM + BZDs demonstrated optimal cost-effectiveness for primary insomnia from a healthcare system perspective, followed by WL and BLM. Limitations in data sources constrain the generalizability of findings. Future studies adopt a societal perspective and incorporate individual-level data over longer time horizons to validate and extend current results through more comprehensive cost-utility evaluations. Furthermore, research should focus on Traditional Chinese medicine (TCM)-specific health utility scales and informing equity-focused reimbursement policies to fully capture the value of CCPPs, thereby ultimately optimizing healthcare access and resource allocation.
More Related Videos
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
05:34Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Management of Insomnia
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Insomnia
Multiple factors contribute...
Blind Procedures